Keyphrases
Berberine
100%
Myocardial Infarction
100%
Liposome-encapsulated
100%
Ventricle Remodeling
100%
Liposomes
28%
Ejection Fraction
21%
Lipopolysaccharide
14%
Reactive Oxygen Species Production
14%
LiPo
14%
Left Ventricular Remodeling
14%
Protective Effect
7%
Beneficial Effects
7%
Interleukin-6
7%
Low Water Solubility
7%
Long-circulating Liposomes
7%
High Dose
7%
C57BL
7%
Congestive Heart Failure
7%
Inflammatory Mediators
7%
Macrophages
7%
Cell Viability
7%
Cardiac Function
7%
Clinical Application
7%
Cytokine Secretion
7%
Echocardiography
7%
Main Determinants
7%
Short Half-life
7%
Intravenous Injection
7%
Male Mice
7%
Mortality Factors
7%
Antioxidant Activity
7%
Preserved Ejection Fraction
7%
Isoquinoline Alkaloids
7%
Barberry
7%
Experimental Diabetes
7%
Cardiac Ischemia-reperfusion Injury
7%
Long-term Administration
7%
Left Anterior Descending Artery
7%
Mouse Macrophage RAW 264.7
7%
Permanent Ligation
7%
Pharmacology, Toxicology and Pharmaceutical Science
Berberine
100%
Liposome
100%
Heart Infarction
100%
Reactive Oxygen Metabolite
14%
Lipopolysaccharide
14%
Anti-Inflammatory Drug
7%
Antioxidant Capacity
7%
Cell Viability
7%
Congestive Heart Failure
7%
Cytokine
7%
Tumor Necrosis Factor
7%
Reperfusion Injury
7%
Heart Muscle Ischemia
7%
Isoquinoline Alkaloid
7%
Experimental Diabetes Mellitus
7%
Interleukin 6
7%